Avanos Medical Balance Sheet Health
Financial Health criteria checks 6/6
Avanos Medical has a total shareholder equity of $1.2B and total debt of $162.0M, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are $1.7B and $426.5M respectively. Avanos Medical's EBIT is $56.3M making its interest coverage ratio 7.6. It has cash and short-term investments of $89.0M.
Key information
13.2%
Debt to equity ratio
US$162.00m
Debt
| Interest coverage ratio | 7.6x |
| Cash | US$89.00m |
| Equity | US$1.23b |
| Total liabilities | US$426.50m |
| Total assets | US$1.66b |
Recent financial health updates
Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Recent updates
What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?
Dec 18Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking
Oct 25There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21Financial Position Analysis
Short Term Liabilities: AVNS's short term assets ($472.6M) exceed its short term liabilities ($212.9M).
Long Term Liabilities: AVNS's short term assets ($472.6M) exceed its long term liabilities ($213.6M).
Debt to Equity History and Analysis
Debt Level: AVNS's net debt to equity ratio (5.9%) is considered satisfactory.
Reducing Debt: AVNS's debt to equity ratio has reduced from 19.6% to 13.2% over the past 5 years.
Debt Coverage: AVNS's debt is well covered by operating cash flow (34.3%).
Interest Coverage: AVNS's interest payments on its debt are well covered by EBIT (7.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Avanos Medical, Inc. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ravi Misra | Berenberg |
| Kristen Stewart | CL King & Associates, Inc. |
| Kristen Stewart | Deutsche Bank |